A Doctor of Molecular Biology, he founded Genomic Vision in 2004, before being appointed as CEO of the company in May 2006. He is also its scientific director.
With over 20 years of professional experience in various financial positions as financial advisor, then within the European leader of clinical diagnostic, Frédéric Tarbouriech joined Genomic Vision in 2017 to manage and finance the development of the business.
PhD, ESCP, COO
Since 2000 Stéphane Altaba has had a significant track record all over the world in deals ranging from early stage licensing compound deals to company acquisitions.